Literature DB >> 15173534

Severe acute respiratory syndrome among children.

Chi-wai Leung1, Yat-wah Kwan, Po-wan Ko, Susan S Chiu, Po-yee Loung, Nai-chung Fong, Lai-ping Lee, Yim-wo Hui, Helen K W Law, Wilfred H S Wong, Kwok-hung Chan, J S Malik Peiris, Wilina W L Lim, Yu-lung Lau, Man-chun Chiu.   

Abstract

OBJECTIVE: To study the epidemiologic, clinical, laboratory, and radiologic features, prognostic indicators, and short-term to medium-term outcomes for children with severe acute respiratory syndrome (SARS) and to validate the performance characteristics of a clinical case definition, calculated with respect to SARS-associated coronavirus (SARS-CoV) seroconversion.
METHODS: Children <18 years of age, from a single-site outbreak, who satisfied a clinical case definition for SARS, with subsequent serologic confirmation, were treated according to a standard protocol and prospectively monitored.
RESULTS: Forty-four children were included. The median age was 12 years. Forty-two children (95.5%) demonstrated an epidemiologic link. Fever, cough, malaise, coryza, sputum production, headache, myalgia, lymphopenia, and elevated lactate dehydrogenase levels were common presenting features. Radiographic findings were nonspecific, but high-resolution computed tomography of the thorax was an early diagnostic aid. A specific reverse transcription-polymerase chain reaction assay for SARS-CoV yielded positive results for <50% of children. Of 9 children who developed hypoxemia, 8 were treated with methylprednisolone. Of 5 children who received intensive care, 3 required assisted ventilation. All children recovered, and serious adverse events in response to treatment were not observed. The outcomes at 3 to 6 months after disease onset, including exercise tolerance, pulmonary functions, and psychologic status, were favorable. An age of >12 years was associated with methylprednisolone therapy for severe illness. After exclusion of the only infant, an age of >12 years was associated with oxygen requirements. Sore throat, high neutrophil count at presentation, and peak neutrophilia were independent factors predicting severe illness. The clinical case definition demonstrated good sensitivity, specificity, and positive and negative predictive values (97.8%, 92.7%, 88%, and 98.7%, respectively) for diagnostic accuracy.
CONCLUSIONS: Children are susceptible to SARS-CoV infection. Teenagers resemble adults with respect to disease progression and may develop severe illness. The short-term to medium-term outcomes are good. Sore throat and initial and peak neutrophilia seem to be predictors of severe illness. Our clinical case definition performed well in the epidemic.

Entities:  

Mesh:

Year:  2004        PMID: 15173534     DOI: 10.1542/peds.113.6.e535

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  58 in total

Review 1.  Epidemiology and management of infectious diseases in international adoptees.

Authors:  Thomas S Murray; M Elizabeth Groth; Carol Weitzman; Michael Cappello
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  The role of maternal antibodies in the emergence of severe disease as a result of fragmentation.

Authors:  David Fouchet; Stéphane Marchandeau; Nargès Bahi-Jaber; Dominique Pontier
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 4.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 5.  Severe acute respiratory syndrome (SARS) in neonates and children.

Authors:  A M Li; P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

6.  Children's vaccines do not induce cross reactivity against SARS-CoV.

Authors:  Yang Yu; Huali Jin; Ze Chen; Qingling L Yu; Yijie J Ma; Xiaolin L Sun; Bin Wang
Journal:  J Clin Pathol       Date:  2007-02       Impact factor: 3.411

Review 7.  SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.

Authors:  Guo-ping Zhao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

8.  Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.

Authors:  Marta L DeDiego; Jose L Nieto-Torres; Jose A Regla-Nava; Jose M Jimenez-Guardeño; Raul Fernandez-Delgado; Craig Fett; Carlos Castaño-Rodriguez; Stanley Perlman; Luis Enjuanes
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells.

Authors:  Helen K W Law; Chung Yan Cheung; Sin Fun Sia; Yuk On Chan; J S Malik Peiris; Yu Lung Lau
Journal:  BMC Immunol       Date:  2009-06-08       Impact factor: 3.615

10.  The SARS-CoV ferret model in an infection-challenge study.

Authors:  Yong-Kyu Chu; Georgia D Ali; Fuli Jia; Qianjun Li; David Kelvin; Ronald C Couch; Kevin S Harrod; Julie A Hutt; Cheryl Cameron; Susan R Weiss; Colleen B Jonsson
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.